PolyPid Ltd. PYPD
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2020-06-26
PolyPid Ltd. statistics & valuation
Market cap$90.6M
P / B8.3×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -153.2% | -115.1% | -155.2% | -152.3% | -96.3% |
| Return on equity | -311.4% | -377.7% | 1138.6% | -678.6% | -118.5% |
| Debt / equity | — | 0.08× | -3.04× | — | — |
| Current ratio | 1.97 | 1.31 | 0.83 | 1.66 | 4.31 |
Source: SEC EDGAR filings · CIK 0001611842 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.